SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-008076
Filing Date
2021-02-24
Accepted
2021-02-24 18:33:17
Documents
2
Period of Report
2021-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1549
2 EX-24 DOCUMENT attachment1.htm EX-24 4156
  Complete submission text file 0000899243-21-008076.txt   7303
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Issuer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 200 SIDNEY STREET, SUITE 320 C/O SYNLOGIC, INC. CAMBRIDGE MA 02139
Business Address
Shegog Todd (Reporting) CIK: 0001714564 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38443 | Film No.: 21675427